Potentially toxic effects of anaesthetics on the developing central nervous system

European Journal of Anaesthesiology

Volumn 24, Issue 3, 2007, Pages 213-224

  Gascon, E ^a   Klauser, P ^a   Kiss, J Z ^a   Vutskits, L ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Anaesthesia; Anaesthetic agents; Apoptosis; Dendrites; Gamma aminobutyric acid; Glutamate; Neurotoxicity

Indexed keywords

4 AMINOBUTYRIC ACID; ANESTHETIC AGENT; BENZODIAZEPINE; DIZOCILPINE; ESTRADIOL; GLUTAMIC ACID; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; KETAMINE; MELATONIN; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; NITRIC OXIDE; NITROUS OXIDE; PROPOFOL;

ANESTHESIA; ANTIOXIDANT ACTIVITY; APOPTOSIS; BRAIN DEVELOPMENT; CELL MIGRATION; CELL PROLIFERATION; DENDRITE; DEVELOPMENTAL STAGE; GABAERGIC TRANSMISSION; HUMAN; INFORMATION PROCESSING; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NERVE DEGENERATION; NEURAL STEM CELL; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

ANESTHETICS; ANIMALS; ANIMALS, NEWBORN; BRAIN; CENTRAL NERVOUS SYSTEM; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; NEUROTOXICITY SYNDROMES;

EID: 33846944295     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021506002365     Document Type: Review

References (113)

1. Hobbs AJ, Bush GH, Downham DY. Peri-operative dreaming and awareness in children. Anaesthesia 1988; 43: 560-562.
2. Anand KS. Relationships between stress responses and clinical outcome in newborns, infants, and children. Crit Care Med 1993; 21: S358-S359.
3. Bouwmeester NJ, Anand KJ, van Dijk M et al. Hormonal and metabolic stress responses after major surgery in children aged 0-3 years: a double-blind, randomized trial comparing the effects of continuous versus intermittent morphine. Br J Anaesth 2001; 87: 390-399.
4. van Lingen RA, Simons SH, Anderson BJ, Tibboel D. The effects of analgesia in the vulnerable infant during the perinatal period. Clin Perinatol 2002; 29: 511-534.
5. Taddio A, Shah V, Gilbert-MacLeod C, Katz J. Conditioning and hyperalgesia in newborns exposed to repeated heel lances. JAMA 2002; 288: 857-861.
6. Tobiansky R, Lui K, Roberts S, Veddovi M. Neurodevelopmental outcome in very low birthweight infants with necrotizing enterocolitis requiring surgery. J Paediatr Child Health 1995; 31: 233-236.
7. Chacko J, Ford WD, Haslam R. Growth and neurodevelopmental outcome in extremely-low-birth-weight infants after laparotomy. Pediatr Surg Int 1999; 15: 496-499.
8. Represa A, Ben-Ari Y. Trophic actions of GABA on neuronal development. Trends Neurosci 2005; 28: 278-283.
9. Waters KA, Machaalani R. NMDA receptors in the developing brain and effects of noxious insults. Neurosignals 2004; 13: 162-174.
10. Nguyen L, Rigo JM, Rocher V et al. Neurotransmitters as early signals for central nervous system development. Cell Tissue Res 2001; 305: 187-202.
11. Herlenius E, Lagercrantz H. Development of neurotransmitter systems during critical periods. Exp Neurol 2004; 190(Suppl 1): S8-S21.
12. Benitez-Diaz P, Miranda-Contreras L, Mendoza-Briceno RV et al. Prenatal and postnatal contents of amino acid neurotransmitters in mouse parietal cortex. Dev Neurosci 2003; 25: 366-374.
13. Lujan R, Shigemoto R, Lopez-Bendito G. Glutamate and GABA receptor signalling in the developing brain. Neuroscience 2005; 130: 567-580.
14. McMahon D. Chemical messengers in development: a hypothesis. Science 1974; 185: 1012-1021.
15. Owens DF, Kriegstein AR. Developmental neurotransmitters? Neuron 2002; 36: 989-991.
16. The Boulder Committee. Embryonic vertebrate central nervous system: revised terminology. Anat Rec 1970; 166: 257-261.
17. Sidman RL, Miale IL, Feder N. Cell proliferation and migration in the primitive ependymal zone: an autoradiographic study of histogenesis in the nervous system. Exp Neurol 1959; 1: 322-333.
18. Altman J. Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb. J Comp Neurol 1969; 137: 433-457.
19. Doetsch F, Caille I, Lim DA et al. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999; 97: 703-716.
20. LoTurco JJ, Owens DF, Heath MJ et al. GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 1995; 15: 1287-1298.
21. Antonopoulos J, Pappas IS, Parnavelas JG. Activation of the GABAA receptor inhibits the proliferative effects of bFGF in cortical progenitor cells. Eur J Neurosci 1997; 9: 291-298.
22. Behar TN, Li YX, Tran HT et al. GABA stimulates chemotaxis and chemokinesis of embryonic cortical neurons via calcium-dependent mechanisms. J Neurosci 1996; 16: 1808-1818.
23. Behar TN, Schaffner AE, Scott CA et al. GABA receptor antagonists modulate postmitotic cell migration in slice cultures of embryonic rat cortex. Cereb Cortex 2000; 10: 899-909.
24. Haydar TF, Wang F, Schwartz ML, Rakic P. Differential modulation of proliferation in the neocortical ventricular and subventricular zones. J Neurosci 2000; 20: 5764-5774.
25. Kornack DR, Rakic P. Changes in cell-cycle kinetics during the development and evolution of primate neocortex. Proc Natl Acad Sci USA 1998; 95: 1242-1246.
26. Liu X, Wang Q, Haydar TF, Bordey A. Nonsynaptic GABA signalling in postnatal subventricular zone controls proliferation of GFAP-expressing progenitors. Nat Neurosci 2005; 8: 1179-1187.
27. Behar TN, Scott CA, Greene CL et al. Glutamate acting at NMDA receptors stimulates embryonic cortical neuronal migration. J Neurosci 1999; 19: 4449-4461.
28. - cotransporter KCC2 and carbonic anhydrase CAVII. J Physiol 2005; 562: 27-36.
29. Miller M. Maturation of rat visual cortex. I. A quantitative study of Golgi-impregnated pyramidal neurons. J Neurocytol 1981; 10: 859-878.
30. Miller M, Peters A. Maturation of rat visual cortex. II. A combined Golgi-electron microscope study of pyramidal neurons. J Comp Neurol 1981; 203: 555-573.
31. McAllister AK. Cellular and molecular mechanisms of dendrite growth. Cereb Cortex 2000; 10: 963-973.
32. Cline HT. Dendritic arbor development and synaptogenesis. Curr Opin Neurobiol 2001; 11: 118-126.
33. Wong RO, Ghosh A. Activity-dependent regulation of dendritic growth and patterning. Nat Rev Neurosci 2002; 3: 803-812.
34. Chen Y, Ghosh A. Regulation of dendritic development by neuronal activity. J Neurobiol 2005; 64: 4-10.
35. Jan YN, Jan LY. The control of dendrite development. Neuron 2003; 40: 229-242.
36. Rajan I, Cline HT. Glutamate receptor activity is required for normal development of tectal cell dendrites in vivo. J Neurosci 1998; 18: 7836-7846.
37. Hensch TK. Critical period regulation. Annu Rev Neurosci 2004; 27: 549-579.
38. Hensch TK. Critical period plasticity in local cortical circuits. Nat Rev Neurosci 2005; 6: 877-888.
39. Liu G. Local structural balance and functional interaction of excitatory and inhibitory synapses in hippocampal dendrites. Nat Neurosci 2004; 7: 373-379.
40. Olney JW. New insights and new issues in developmental neurotoxicology. Neurotoxicology 2002; 23: 659-668.
41. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969; 164: 719-721.
42. Olney JW, Sharpe LG. Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science 1969; 166: 386-388.
43. Ikonomidou C, Bosch F, Miksa M et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999; 283: 70-74.
44. Asada H, Kawamura Y, Maruyama K et al. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 1997; 94: 6496-6499.
45. Hensch TK, Fagiolini M, Mataga N et al. Local GABA circuit control of experience-dependent plasticity in developing visual cortex. Science 1998; 282: 1504-1508.
46. Adams SM, de Rivero Vaccari JC, Corriveau RA. Pronounced cell death in the absence of NMDA receptors in the developing somatosensory thalamus. J Neurosci 2004; 24: 9441-9450.
47. Li Y, Erzurumlu RS, Chen C et al. Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell 1994; 76: 427-437.
48. Iwasato T, Datwani A, Wolf AM et al. Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex. Nature 2000; 406: 726-731.
49. Ikonomidou C, Bittigau P, Ishimaru MJ et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000; 287: 1056-1060.
50. Albers GW, Goldberg MP, Choi DW. N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia? Ann Neurol 1989; 25: 398-403.
51. Bullock R. Strategies for neuroprotection with glutamate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies. Ann NY Acad Sci 1995; 765: 272-278discussion 298.
52. Himmelseher S, Durieux ME. Revising a dogma: ketamine for patients with neurological injury? Anesth Analg 2005; 101: 524-534.
53. Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989; 244: 1360-1362.
54. Scallet AC, Divine R, Wang C et al. Ketamine-induced neurotoxicity in prenatal rhesus monkeys: distribution of neuronal damage. Soc Neurosci Abst 2005: 251.15.
55. Hayashi H, Dikkes P, Soriano SG. Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth 2002; 12: 770-774.
56. Scallet AC, Schmued LC, Slikker Wet al. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci 2004; 81: 364-370.
57. Young C, Jevtovic-Todorovic V, Qin YQ et al. Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br J Pharmacol 2005; 146: 189-197.
58. Webb SJ, Monk CS, Nelson CA. Mechanisms of postnatal neurobiological development: implications for human development. Dev Neuropsychol 2001; 19: 147-171.
59. Gascon E, Vutskits L, Zhang H et al. Sequential activation of p75 and TrkB is involved in dendritic development of subventricular zone-derived neuronal progenitors in vitro. Eur J Neurosci 2005; 21: 69-80.
60. Malinovsky JM, Servin F, Cozian A et al. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children. Br J Anaesth 1996; 77: 203-207.
61. Weber F, Wulf H, Gruber M, Biallas R. S-ketamine and S-norketamine plasma concentrations after nasal and i.v. administration in anesthetized children. Paediatr Anaesth 2004; 14: 983-988.
62. Vutskits L, Gascon E, Tassonyi E, Kiss JZ. Effect of ketamine on dendritic arbor development and survival of immature GABAergic neurons in vitro. Toxicol Sci 2006; e-pub ahead.
63. Adams HA. Mechanisms of action of ketamine. Anaesthesiol Reanim 1998; 23: 60-63.
64. Kari HP, Davidson PP, Kohl HH, Kochhar MM. Effects of ketamine on brain monoamine levels in rats. Res Commun Chem Pathol Pharmacol 1978; 20: 475-488.
65. Tso MM, Blatchford KL, Callado LF et al. Stereoselective effects of ketamine on dopamine, serotonin and noradrenaline release and uptake in rat brain slices. Neurochem Int 2004; 44: 1-7.
66. Nishimura M, Sato K, Okada T et al. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology 1998; 88: 768-774.
67. Bozzi Y, Borrelli E. Dopamine in neurotoxicity and neuroprotection: what do D(2) receptors have to do with it? Trends Neurosci 2006; 29: 167-174.
68. McKittrick CR, Magarinos AM, Blanchard DC et al. Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites. Synapse 2000; 36: 85-94.
69. Mazar J, Rogachev B, Shaked G et al. Involvement of adenosine in the antiinflammatory action of ketamine. Anesthesiology 2005; 102: 1174-1181.
70. Tebano MT, Martire A, Rebola N et al. Adenosine A2A receptors and metabotropic glutamate 5 receptors are co-localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N-methyl-D-aspartate effects. J Neurochem 2005; 95: 1188-1200.
71. Keilhoff G, Bernstein HG, Becker A et al. Increased neurogenesis in a rat ketamine model of schizophrenia. Biol Psychiatry 2004; 56: 317-322.
72. Bjönström K, Sjölander A, Schippert A, Eintrei C. A tyrosine kinase regulates propofol-induced modulation of the b-subunit of the GABAA receptor and release of intracellular calcium in cortical rat neurons. Acta Physiol Scand 2002; 175: 227-235.
73. Wooltorton E. Propofol contraindicated for sedation of pediatric intensive care patients. CMAJ 2002; 167: 507.
74. Crawford MW, Dodgson BG, Holtby HH, Roy WL. Propofol syndrome in children. CMAJ 2003; 168: 669author reply 669-70.
75. Westrin P. The induction dose of propofol in infants 1-6 months of age and in children 10-16 years of age. Anesthesiology 1991; 74: 455-458.
76. Murat I, Billard V, Vernois J et al. Pharmacokinetics of propofol after a single dose in children aged 1-3 years with minor burns. Comparison of three data analysis approaches. Anesthesiology 1996; 84: 526-532.
77. Honegger P, Matthieu JM. Selective toxicity of the general anesthetic propofol for GABAergic neurons in rat brain cell cultures. J Neurosci Res 1996; 45: 631-636.
78. Spahr-Schopfer I, Vutskits L, Toni N et al. Differential neurotoxic effects of propofol on dissociated cortical cells and organotypic hippocampal cultures. Anesthesiology 2000; 92: 1408-1417.
79. Vutskits L, Gascon E, Tassonyi E, Kiss JZ. Clinically relevant concentrations of propofol but not midazolam alter in vitro dendritic development of isolated gamma-aminobutyric acid-positive interneurons. Anesthesiology 2005; 102: 970-976.
80. Arcangeli A, Antonelli M, Mignani V, Sandroni C. Sedation in PACU: the role of benzodiazepines. Curr Drug Targets 2005; 6: 745-748.
81. Mohler H, Fritschy JM, Vogt K et al. Pathophysiology and pharmacology of GABAA receptors. Handb Exp Pharmacol 2005; 169: 225-247.
82. Stephenson FA, Duggan MJ, Pollard S. The gamma 2 subunit is an integral component of the gamma-aminobutyric acidA receptor but the alpha 1 polypeptide is the principal site of the agonist benzodiazepine photoaffinity labeling reaction. J Biol Chem 1990; 265: 21160-21165.
83. Orser BA, Bertlik M, Wang LY, MacDonald JF. Inhibition by propofol (2,6 diisopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br J Pharmacol 1995; 116: 1761-1768.
84. Flood P, Ramirez-Latorre J, Role L. Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected. Anesthesiology 1997; 86: 859-865.
85. 2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents. J Neurophysiol 1998; 79: 240-252.
86. Oscarsson A, Massoumi R, Sjolander A, Eintrei C. Reorganization of actin in neurons after propofol exposure. Acta Anaesthesiol Scand 2001; 45: 1215-1220.
87. A receptor beta subunit and vary in their interaction with actin. Acta Anaesthesiol Scand 2003; 47: 157-164.
88. Uemura E, Bowman RE. Effects of halothane on cerebral synaptic density. Exp Neurol 1980; 69: 135-142.
89. Uemura E, Levin ED, Bowman RE. Effects of halothane on synaptogenesis and learning behavior in rats. Exp Neurol 1985; 89: 520-529.
90. Levin ED, Uemura E, Bowman RE. Neurobehavioral toxicology of halothane in rats. Neurotoxicol Teratol 1991; 13: 461-470.
91. Wise-Faberowski L, Zhang H, Ing R et al. Isofluraneinduced neuronal degeneration: an evaluation in organotypic hippocampal slice cultures. Anesth Analg 2005; 101: 651-657.
92. Stratmann G, Bickler P, Ku B et al. Isoflurane increases stem cell proliferation in adult but not in rat neonatal hippocampi. Soc Neurosci Abst 2005; 826-829.
93. Mullenix PJ, Moore PA, Tassinari MS. Behavioral toxicity of nitrous oxide in rats following prenatal exposure. Toxicol Ind Health 1986; 2: 273-287.
94. Jevtovic-Todorovic V, Benshoff N, Olney JW. Ketamine potentiates cerebrocortical damage induced by the common anaesthetic agent nitrous oxide in adult rats. Br J Pharmacol 2000; 130: 1692-1698.
95. Jevtovic-Todorovic V, Hartman RE, Izumi Y et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003; 23: 876-882.
96. Lu LX, Yon JH, Carter LB, Jevtovic-Todorovic V. General anesthesia activates BDNF-dependent neuroapotosis in the developing brain. Apoptosis 2006; May30 (Epub ahead of print).
97. Tenq KK, Hempstead BL. Neurotrophins and their receptors: signaling trios in complex biological systems. Cell Mol Life Sci 2004; 61: 35-48.
98. Yon JH, Carter LB, Reiter RJ, Jevtovic-Todorovic V. Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol Dis 2006; 21: 522-530.
99. Berde C, Cairns B. Developmental pharmacology across species: promise and problems. Anesth Analg 2000; 91: 1-5.
100. Rizzi S, Carter LB, Jevtovic-Todorovic V. Clinically used general anesthetics induce neuroapoptosis in the developing piglet brain. Soc Neurosci Abst 2005; 251.7.
101. Anand KJ, Soriano SG. Anesthetic agents and the immature brain: are these toxic or therapeutic? Anesthesiology 2004; 101: 527-530.
102. Clancy B, Darlington RB, Finlay BL. Translating developmental time across mammalian species. Neuroscience 2001; 105: 7-17.
103. Roytblat L, Talmor D, Rachinsky M et al. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth Analg 1998; 87: 266-271.
104. Zilberstein G, Levy R, Rachinsky M et al. Ketamine attenuates neutrophil activation after cardiopulmonary bypass. Anesth Analg 2002; 95: 531-536.
105. Lipton SA, Nakanishi N. Shakespeare in love - with NMDA receptors? Nat Med 1999; 5: 270-271.
106. Bhutta AT, Anand KJ. Vulnerability of the developing brain. Neuronal mechanisms. Clin Perinatol 2002; 29: 357-372.
107. Olney JW, Young C, Wozniak DF et al. Anesthesia-induced developmental neuroapoptosis. Does it happen in humans? Anesthesiology 2004; 101: 273-275.
108. Dobbing J. Undernutrition and the developing brain. The relevance of animal models to the human problem. Am J Dis Child 1970; 120: 411-415.
109. Lucas A, Morley R, Cole TJ. Randomised trial of early diet in preterm babies and later intelligence quotient. BMJ 1998; 317: 1481-1487.
110. Todd MM. Anesthetic neurotoxicity: the collision between laboratory neuroscience and clinical medicine. Anesthesiology 2004; 101: 272-273.
111. AHRQ:HCUPnet: Healthcare Cost and Utilization Project, Rockville, MD, Agency for Healthcare Research and Quality, 2001 (www.ahrq.gov/hcupnet).
112. Cohen MM, Cameron CB, Duncan PG. Pediatric anesthesia morbidity and mortality in the perioperative period. Anesth Analg 1990; 70: 160-167.
113. Anand KJ, Aranda JV, Berde CB et al. Analgesia and anesthesia for neonates: study design and ethical issues. Clin Ther 2005; 27: 814-843.